| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 01/27/2011 | US20110021563 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| 01/27/2011 | US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 01/27/2011 | CA2768963A1 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
| 01/27/2011 | CA2763952A1 Process for preparing nebivolol |
| 01/26/2011 | EP2277880A1 Macrolides with VEGF transcription suppression activity |
| 01/26/2011 | EP2276747A1 Sulfonamides as zap-70 inhibitors |
| 01/26/2011 | EP2089361B1 Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 01/26/2011 | EP1633733B1 Cannabinoid derivatives, methods of making, and use thereof |
| 01/26/2011 | CN101955479A Method for extracting orientin from bamboo leaf |
| 01/26/2011 | CN101955478A Preparation of brominated flavanonollignan and application in medicine for treating viral hepatitis B |
| 01/26/2011 | CN101282967B Total synthesis of pladienolide b and pladienolide D |
| 01/20/2011 | WO2011008709A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | WO2011006355A1 Compounds as hypoxia mimetics, and compositions, and uses thereof |
| 01/20/2011 | US20110015413 Process for preparing crystalline calcium mupirocin dihydrate |
| 01/20/2011 | CA2767911A1 Compounds as hypoxia mimetics, and compositions, and uses thereof |
| 01/20/2011 | CA2767894A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | CA2767887A1 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 01/19/2011 | EP2275418A1 Chromene compound |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2274302A2 Compounds and compositions as itpkb inhibitors |
| 01/19/2011 | EP2274293A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby |
| 01/19/2011 | EP2274288A2 Macrocyclic compounds and their use as kinase inhibitors |
| 01/19/2011 | EP2274282A1 Compounds for use in stabilizing p53 mutants |
| 01/19/2011 | CN101952270A Process for preparing nebivolol |
| 01/19/2011 | CN101948456A Rhizoma zedoariae inner ester derivant with antitumor activity and preparation method thereof |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101072773B Pyrrole derivatives having CRTH2 receptor antagonist activity |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | CA2511301C Acylsufonamide compounds as inhibitors of rna-dependent rna viral polymerase |
| 01/13/2011 | WO2011005660A1 Tofa analogs useful in treating dermatological disorders or conditions |
| 01/13/2011 | WO2011004017A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | WO2010101839A3 Chemiluminescent compositions, methods, assays and kits for oxidative enzymes |
| 01/13/2011 | US20110006670 Organic electroluminescence element, new compound for the same, display device and lighting device using the same |
| 01/13/2011 | CA2766643A1 Tofa analogs useful in treating dermatological disorders or conditions |
| 01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
| 01/12/2011 | EP2271641A1 Fungicide hydroximoyl-heterocycles derivatives |
| 01/12/2011 | EP2271638A1 Modulators of dopamine neurotransmission |
| 01/12/2011 | CN101945851A Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 01/12/2011 | CN101945580A Azolylmethyloxiranes, use thereof and agents containing the same |
| 01/12/2011 | CN101941966A Method for extracting high-purity puerarin |
| 01/12/2011 | CN101094851B Novel compound having lipase inhibitory activity |
| 01/12/2011 | CN101081848B Novel polyenes and preparation method and usage thereof |
| 01/11/2011 | US7868225 Artichoke hybrid named ‘PS-H2015’ |
| 01/11/2011 | US7868191 salt formation; no-toxic reagents; shorter production process, and commercially and environmentally friendly |
| 01/06/2011 | WO2011002984A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands |
| 01/06/2011 | WO2011001419A1 Covalent inhibition of bacterial quorum sensing |
| 01/06/2011 | US20110003861 2-aryl and 2-heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain |
| 01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 01/06/2011 | US20110002947 Leptomycin derivatives |
| 01/06/2011 | CA2767183A1 Covalent inhibition of bacterial quorum sensing |
| 01/05/2011 | EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands |
| 01/05/2011 | EP2268633A1 Pyridazinone glucokinase activators |
| 01/05/2011 | EP2268628A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain |
| 01/05/2011 | EP2268615A1 Pesticides |
| 01/05/2011 | EP1633726B1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | CN101935303A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors |
| 01/04/2011 | US7863464 Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
| 01/04/2011 | CA2543722C Tocopherol-modified therapeutic drug compounds |
| 01/04/2011 | CA2493995C Macrolide compounds endowed with antiinflammatory activity |
| 12/30/2010 | US20100331554 Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
| 12/30/2010 | US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors |
| 12/29/2010 | WO2010151791A1 Heterocyclic compounds and their uses |
| 12/29/2010 | WO2010149956A1 4 -aminopicolinates and their use as herbicides |
| 12/29/2010 | WO2010149755A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17 |
| 12/29/2010 | WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides |
| 12/29/2010 | EP2266978A1 Novel physiologically active substances |
| 12/29/2010 | EP2266958A1 Antiviral agent |
| 12/29/2010 | EP2265118A2 Fungicide hydroximoyl-tetrazole derivatives |
| 12/29/2010 | CN101928244A Structural analogue and derivative of isochromanone-4 compound with cardiovascular activity, preparation method and application thereof |
| 12/29/2010 | CN101926788A Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof |
| 12/29/2010 | CN101200465B Decahydronaphthalene compounds and medical uses thereof |
| 12/29/2010 | CA2765983A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17 |
| 12/29/2010 | CA2765823A1 Tricyclic heterocyclic compounds as mediators of p13k activity |
| 12/29/2010 | CA2764200A1 4 -aminopicolinates and their use as herbicides |
| 12/28/2010 | USRE42015 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
| 12/28/2010 | US7858644 administering prostaglandin receptor antagonists such as N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide, used analgesics, neuroprtectants and diuretics, or for the treament of diabetes, tinitus, cancer, bone, blood, sleep, cardiovascular and sexual disorders |
| 12/23/2010 | WO2010072770A3 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| 12/23/2010 | US20100324131 Salvinorin Derivatives and Uses Thereof |
| 12/23/2010 | US20100324009 Substituted Sulfonamide Compounds |
| 12/23/2010 | US20100323999 Therapeutic Molecules and Methods-1 |
| 12/22/2010 | EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 12/22/2010 | EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors |
| 12/22/2010 | CN1894209B Prostaglandin synthesis |
| 12/22/2010 | CN1802366B C-glycoside derivatives and salts thereof |
| 12/22/2010 | CN101921270A Mangiferin berberine salt, preparation method thereof and use thereof |
| 12/22/2010 | CN101920128A Method for obtaining extractive by solvent extraction method under conditions of pressurization and ultrasonic irradiation |
| 12/22/2010 | CN101919840A Application of B/E ring substituted silybin for preparing medicament for treating virus hepatitis B |
| 12/22/2010 | CN101318955B Method for preparing effective component of kudzu root |
| 12/21/2010 | US7855207 such as 6-[(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-piperidin-1-ylpropyl]-3-ethyl-1H-quinolin-2-one, used for treating cancer and/or preventing cellular, tissue and/or organ damage resulting from cell damage or death due to, for example, necrosis or apoptosis |
| 12/21/2010 | CA2452596C Benzo-fused 5-membered heterocyclic compounds, their production and use |
| 12/21/2010 | CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/16/2010 | WO2010144647A1 Nicotinamide compounds useful as kinase modulators |
| 12/16/2010 | WO2010143733A1 Novel fused cyclic compound and use thereof |
| 12/16/2010 | WO2010142864A1 N-type organic semiconductors including at least two 2-dicyanomethylene-3-cyano-2,5-dihydrofuran groups |
| 12/16/2010 | WO2010142663A1 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof |
| 12/16/2010 | WO2010129467A8 Compounds and methods for inhibition of renin, and indications therefor |
| 12/16/2010 | WO2010116088A3 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof |
| 12/16/2010 | US20100317659 Jak kinase modulating compounds and methods of use thereof |
| 12/16/2010 | US20100317644 Substituted Sulfonamide Compounds |